EGM
TXMD icon

Engineers Gate Manager’s TherapeuticsMD TXMD Stock Holding History

Engineers Gate Manager’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-358
Closed -$24K – 2028
2021
Q1 		$24K Buy
358
+90
+34% +$7.04K ﹤0.01% 1766
2020
Q4 		$16K Buy
+268
New +$18.3K ﹤0.01% 1651

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Engineers Gate Manager's TXMD Position: Q2 2021 in Review

Engineers Gate Manager sold out of TherapeuticsMD (TXMD) in Q2 2021, closing a stake of 358 shares — an estimated $24K sold.

Engineers Gate Manager first reported a position in TXMD in Q4 2020 and held it in 2 quarters. The position peaked at $24K in Q1 2021. 154 funds tracked by Wall St. Rank hold TXMD as of Q2 2021.

  • Engineers Gate Manager reported no remaining TherapeuticsMD position as of Q2 2021 after selling out during the quarter.
  • Engineers Gate Manager sold 358 TherapeuticsMD shares in Q2 2021, an estimated $24K.
  • Engineers Gate Manager first reported a position in TherapeuticsMD in Q4 2020 and held it in 2 quarters.
  • Engineers Gate Manager's TherapeuticsMD position peaked at $24K in Q1 2021.
  • 154 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2021.

Based on Engineers Gate Manager's 13F filing for Q2 2021, filed 16 Aug 2021.